Immune thrombocytopenia: Getting back to basics

American Journal of Hematology

Volumn 87, Issue 9, 2012, Pages 841-842

  Arnold, Donald M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEMATOLOGIC AGENT; IMMUNOGLOBULIN; RITUXIMAB; THROMBOCYTE ANTIBODY; THROMBOPOIETIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EXERCISE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE THROMBOCYTOPENIA; NOTE; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; UNITED STATES;

FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL RECORDS; POPULATION SURVEILLANCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 84865388677     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23287     Document Type: Note

References (21)

1. Imbach P, Kuhne T, Signer E. Historical aspects and present knowledge of idiopathic thrombocytopenic purpura. Br J Hematol 2002; 119: 894-900.
2. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 1984; 6: 165-169.
3. Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228-1231.
4. Arnold DM, Dentali F, Crowther MA, et al. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007; 146: 25-33.
5. Cheng G, Saleh MN, Marcher C, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): A 6-month, randomized, phase 3 study. Lancet 2011; 377: 393-402.
6. Kuter DJ, Rummel M, Boccia R, et al. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med 2010; 363: 1889-1899.
7. Toltl LJ, Nazi I, Jafari R, Arnold DM. Piecing together the humoral and cellular mechanisms of immune thrombocytopenia. Semin Thromb Hemost 2011; 37: 631-639.
8. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
9. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996; 87: 4245-4254.
10. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood 2009; 113: 6511-6521.
11. Arnold DM, Heddle NM, Carruthers J, et al. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood 2012; 119: 1356-1362.
12. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113: 2386-2393.
13. Terrell D, Beebe L, Vesely SK, et al. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol 2012; 87.
14. Terrell D, Beebe L, Neas B, et al. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol 2012; 87.
15. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Intern Med 1998; 129: 886-890.
16. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Hemost 2006; 4: 759-765.
17. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-1330.
18. Bennett D, Hodgson ME, Shukla A, Logie JW. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom. Adv Ther 2011; 28: 1096-1104.
19. Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: Analysis of a large US claim database: A rebuttal. J Thromb Hemost 2008; 6: 711-712.
20. Hedman A, Henter JI, Hedlund I, Elinder G. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Pediatr 1997; 86: 226-227.
21. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: Analyses of administrative data. J Thromb Hemost 2006; 4: 2377-2383.